doi: 10.2147/OTT.S312745.
eCollection 2021.
LncRNA ANRIL Regulates Ovarian Cancer Progression and Tumor Stem Cell-Like Characteristics via miR-324-5p/Ran Axis [Retraction]
- PMID: 33833521
- PMCID: PMC8019665
- DOI: 10.2147/OTT.S312745
Item in Clipboard
LncRNA ANRIL Regulates Ovarian Cancer Progression and Tumor Stem Cell-Like Characteristics via miR-324-5p/Ran Axis [Retraction]
Onco Targets Ther.
.
Abstract
[This retracts the article DOI: 10.2147/OTT.S273614.].
© 2021 Dove Medical Press.
Retraction of
-
LncRNA ANRIL Regulates Ovarian Cancer Progression and Tumor Stem Cell-Like Characteristics via miR-324-5p/Ran Axis.Onco Targets Ther. 2021 Jan 19;14:565-576. doi: 10.2147/OTT.S273614. eCollection 2021. Onco Targets Ther. 2021. Retraction in: Onco Targets Ther. 2021 Mar 30;14:2235. doi: 10.2147/OTT.S312745. PMID: 33500630 Free PMC article. Retracted.
Similar articles
-
LncRNA ANRIL Regulates Ovarian Cancer Progression and Tumor Stem Cell-Like Characteristics via miR-324-5p/Ran Axis.Onco Targets Ther. 2021 Jan 19;14:565-576. doi: 10.2147/OTT.S273614. eCollection 2021. Onco Targets Ther. 2021. Retraction in: Onco Targets Ther. 2021 Mar 30;14:2235. doi: 10.2147/OTT.S312745. PMID: 33500630 Free PMC article. Retracted.
-
lncRNA HAND2-AS1 Regulates Prostate Cancer Cell Growth Through Targeting the miR-106a-5p/RBM24 Axis [Retraction].Onco Targets Ther. 2022 Jan 28;15:133-134. doi: 10.2147/OTT.S359036. eCollection 2022. Onco Targets Ther. 2022. PMID: 35115788 Free PMC article.
-
LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis [Retraction].Onco Targets Ther. 2022 Jun 15;15:681-682. doi: 10.2147/OTT.S378352. eCollection 2022. Onco Targets Ther. 2022. PMID: 35733651 Free PMC article.
-
LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis [Retraction].Cancer Manag Res. 2022 Dec 15;14:3457-3458. doi: 10.2147/CMAR.S401333. eCollection 2022. Cancer Manag Res. 2022. PMID: 36545223 Free PMC article.
-
The lncRNA LINC01194/miR-486-5p Axis Facilitates Malignancy in Non-Small Cell Lung Cancer via Regulating CDK4 [Retraction].Onco Targets Ther. 2024 Feb 23;17:147-148. doi: 10.2147/OTT.S465182. eCollection 2024. Onco Targets Ther. 2024. PMID: 38420288 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
